Published in Medical Letter on the CDC and FDA, June 21st, 2006
The results were presented at a major medical meeting.
Symbyax is the first and currently the only acute treatment approved by the U.S. Food and Drug Administration (FDA) for the depressive phase of bipolar disorder. The World Health Organization estimates...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA